Literature DB >> 16931992

Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.

Tatsuya Hashimoto1, Yoji Saito, Kazuo Yamada, Nobumasa Hara, Yumiko Kirihara, Mikako Tsuchiya.   

Abstract

BACKGROUND: Morphine can desensitize mu-opioid receptor (MOR), but it does not cause internalization of the receptor after binding. Acute desensitization of MOR impairs the efficiency of signaling, whereas the receptor internalization restores the cell responsiveness to the agonists. Thereby, the property of morphine may limit the analgesic effects of this opiate drug. It has been shown that [D-Ala2,MePhe4,Gly-ol5]enkephalin (DAMGO), a potent MOR agonist inducing the internalization, facilitates morphine to internalize MOR, suggesting that MOR agonists with low relative activity versus endocytosis (RAVE) values such as DAMGO can potentiate analgesic effects of morphine through stimulating MOR internalization. The authors examined whether the acute analgesic effect of morphine can be potentiated by low relative activity versus endocytosis agonists DAMGO and fentanyl.
METHODS: Rats injected intrathecally with opioids were subjected to a hot plate test for antinociceptive effect. Immunostained spinal dorsal horn was analyzed by confocal microscopy.
RESULTS: Fentanyl induced MOR internalization to a lesser extent than DAMGO at equianalgesic doses. Coadministration of fentanyl promoted morphine-induced MOR internalization. The analgesic effect of morphine was greatly potentiated together with decrease in the relative activity versus endocytosis value when MOR internalization was induced by coadministration of a subanalgesic dose of DAMGO or fentanyl. In contrast, the combination of DAMGO and fentanyl increased neither the analgesic effect nor the internalization of MOR.
CONCLUSIONS: The results suggest that the coadministration of morphine with MOR-internalizing agonist is clinically applicable to develop successful pain-management regimens to achieve satisfactory analgesia using less morphine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931992     DOI: 10.1097/00000542-200609000-00023

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  Opioid-Induced Tolerance and Hyperalgesia.

Authors:  Sebastiano Mercadante; Edoardo Arcuri; Angela Santoni
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization.

Authors:  S Puig; K E Barker; S R Szott; P T Kann; J S Morris; H B Gutstein
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

5.  Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Francesca Felicia Caputi; Francesca Lattanzio; Donatella Carretta; Daniela Mercatelli; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2013-05-29       Impact factor: 3.444

6.  Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanyl.

Authors:  Laura Anselmi; Ingrid Jaramillo; Michelle Palacios; Jennifer Huynh; Catia Sternini
Journal:  J Neurosci Res       Date:  2013-03-29       Impact factor: 4.164

7.  Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.

Authors:  Christian Zöllner; Shaaban A Mousa; Oliver Fischer; Heike L Rittner; Mohammed Shaqura; Alexander Brack; Mehdi Shakibaei; Waltraud Binder; Florian Urban; Christoph Stein; Michael Schäfer
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Chronopharmacodynamics and chronopharmacokinetics of pethidine in mice.

Authors:  Chengliang Zhang; Zaoqin Yu; Xiping Li; Yanjiao Xu; Dong Liu
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.